Abstract The Asia–Pacific Consensus Conference was convened to review and synthesize
the most current information on Helicobacter pylori management so as to update the …

Background The optimal duration for Helicobacter pylori (H. pylori) eradication therapy is
controversial, with recommendations ranging from 7 to 14 days. Several systematic reviews …

Helicobacter pylori (H. pylori) remains a prevalent, worldwide, chronic infection. Though the
prevalence of this infection appears to be decreasing in many parts of the world, H. pylori …

Background Thousands of systematic reviews have been conducted in all areas of health
care. However, the methodological quality of these reviews is variable and should routinely …

Helicobacter pylori (H. pylori) is an important major cause of peptic ulcer disease and gastric
malignancies such as mucosa-associated lymphoid tissue lymphoma and gastric …

OBJECTIVES: Recent treatment guidelines recommend two first-line therapies
forHelicobacter pyloriinfection: proton pump inhibitor (PPI), bismuth, tetracycline, and …

Background: In areas with high clarithromycin resistance, bismuth quadruple therapy (BQT)
is recommended instead of clarithromycin triple therapy (CTT) as the first-line treatment for …

Helicobacter pylori colonizes the mucus layer of the human stomach and duodenum, causes
chronic gastritis, gastric ulcer, and is a risk factor for gastric adenocarcinoma. There is a 20 …

Eradication therapy for Helicobacter pylori is recommended in a number of clinical
conditions. In this article, we discuss the epidemiology and cellular mechanisms that result …

How to Effectively Use Bismuth Quadruple Therapy - Gastroenterology Clinics Skip to Main
Content Skip to Main Menu Advertisement Gastroenterology Clinics Log in Register Log in …